Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Cerevel Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2018 Unicorn

Cerevel Therapeutics is a biopharmaceutical company. Boston Massachusetts

Valuation
$6.87B
Market cap · 2026

Investors

1 investor on Cerevel Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Global footprint

Where Cerevel Therapeutics has talent and traffic

Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown
Web traffic by country
530 monthly visits
across markets
🇮🇱 Israel94.3%
Top 1 markets shown

Patent intelligence

$82k patent portfolio · 3 active families

Estimated portfolio value
$82k
<0.01% of market cap · 212.4× smaller than top peer Sinovent ($17M)
3 active patent families
Where Cerevel Therapeutics innovates Pharmaceutical SubstancesMedicinal chemistryAzepindolePhosphodiesterase inhibitorPharmaceutical drug

Where Cerevel Therapeutics concentrates vs peers

Each axis is a top-10 topic across Cerevel Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Cerevel Therapeutics

An AI-synthesized read of the highest-engagement posts about Cerevel Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cerevel Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.